fingolimod hydrochloride has been researched along with Scleroderma, Localized in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujimoto, M; Hamaguchi, Y; Hasegawa, M; Huu, DL; Jin, G; Matsushita, T; Takehara, K | 1 |
1 other study(ies) available for fingolimod hydrochloride and Scleroderma, Localized
Article | Year |
---|---|
FTY720 ameliorates murine sclerodermatous chronic graft-versus-host disease by promoting expansion of splenic regulatory cells and inhibiting immune cell infiltration into skin.
Topics: Animals; Bone Marrow Transplantation; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Fingolimod Hydrochloride; Flow Cytometry; Graft vs Host Disease; Immunohistochemistry; Immunosuppressive Agents; Male; Mice; Propylene Glycols; PTEN Phosphohydrolase; Reverse Transcriptase Polymerase Chain Reaction; Scleroderma, Localized; Skin; Sphingosine; Spleen | 2013 |